Therapeutic effects of organic Germanium
Data up to Jan 2025
Total Citations Per Year
Abstract
References (45)
CD8 + Lymphocytes Can Control HIV Infection in Vitro by Suppressing Virus Replication
1986 • 1,010 citations
THE EFFECT OF COLCHICINE ON ROOT MITOSES IN ALLIUM
2010 • 564 citations
The AIDS Virus
1987 • 204 citations
The First Human Retrovirus
1986 • 168 citations
Induction of Interferon and Activation of NK Cells and Macrophages in Mice by Oral Administration of Ge‐132, an Organic Germanium Compound
1985 • 99 citations
Accumulation of germanium in the tissues of a long-term user of germanium preparation died of acute renal failure.
1985 • 75 citations
Antiarthritic and immunoregulatory activity of spirogermanium.
1986 • 50 citations
Abnormal trace metals in man: Germanium
1967 • 48 citations
Spirans XXII. Synthesis of 4,4‐dialkyl‐4‐germacyclohexanone and 8,8‐dialkyl‐8‐germaazaspiro [4.5] decanes
1974 • 44 citations
Cytotoxic effects and biological activity of 2-aza-8-germanspiro[4,5]-decane-2-propanamine-8,8-diethyl-N,N-dimethyl dichloride (NSC 192965; spirogermanium) in vitro.
1982 • 41 citations
Antitumor effect of the organogermanium compound Ge-132 on the Lewis lung carcinoma (3LL) in C57Bl/6 (B6) mice.
1985 • 39 citations
Cooperation of lymphokine(s) and macrophages in expression of antitumor activity of carboxyethylgermanium sesquioxide (Ge-132).
1986 • 38 citations
Phase I clinical trial of spirogermanium.
1980 • 37 citations
Generation of suppressor cells in normal rats by treatment with spirogermanium, a novel heterocyclic anticancer drug
1985 • 28 citations
Importance of T-cells and macrophages in the antitumor activity of carboxyethylgermanium sesquioxide (Ge-132).
1985 • 27 citations
Phase II trial of spirogermanium for treatment of advanced breast cancer.
1983 • 24 citations
Restoration of Impaired Immunoresponse by Germanium in Mice
1980 • 22 citations
Phase II study of spirogermanium in advanced ovarian malignancy.
1981 • 21 citations
Determination of germanium in medicinal plants by atomic absorption spectrometry with electrothermal atomization.
1980 • 18 citations
Prevention of Suppressed Interferon Gamma Production in Thermally Injured Mice by Administration of a Novel Organogermanium Compound, Ge-132
1984 • 17 citations
Analgesic effect of novel organogermanium compound, Ge-132.
1983 • 16 citations
A phase II study of spirogermanium in advanced human malignancy
1985 • 16 citations
Identification of synergistic combinations of spirogermanium with 5-fluorouracil or cisplatin using a range of human tumour cell lines in vitro
1984 • 16 citations
Inhibition of tumor growth and metastasis in association with modification of immune response by novel organic germanium compounds.
1985 • 11 citations
Effect of spirogermanium on V79 Chinese hamster cells
1983 • 11 citations
A Phase I trial of spirogermanium administered on a continuous infusion schedule
1984 • 11 citations
Spirogermanium: a new drug with antimalarial activity against chloroquine-resistant Plasmodium falciparum.
1983 • 10 citations
[Antitumor activity of Ge-132, a new organogermanium compound, in mice is expressed through the functions of macrophages and T lymphocytes].
1985 • 10 citations
A phase II study of spirogermanium in patients with metastatic malignant melanoma
1985 • 9 citations
Phase II study of spirogermanium in advanced breast cancer.
1984 • 9 citations
Phase II study of spirogermanium in advanced (extensive) non-small cell lung cancer.
1986 • 8 citations
A phase II study of spirogermanium as second line therapy in patients with poor prognosis lymphoma
1985 • 8 citations
Phase II study of spirogermanium in patients with advanced carcinoma of the cervix.
1985 • 7 citations
Phase II trial of spirogermanium in advanced renal cell carcinoma: a Cancer and Leukemia Group B study.
1984 • 7 citations
[Suppression of tumor growth by peritoneal macrophages isolated from mice treated with carboxyethylgermanium sesquioxide (Ge-132)].
1985 • 7 citations
Phase II evaluation of spirogermanium in advanced ovarian carcinoma.
1983 • 6 citations
[Augmentation of NK activity in peripheral blood lymphocytes of cancer patients by intermittent GE-132 administration].
1984 • 6 citations
Phase II study of spirogermanium in metastatic prostate cancer.
1986 • 6 citations
Inhibitory effects of Ge-132 (carboxyethyl germanium sesquioxide) derivatives on enkephalin-degrading enzymes.
1986 • 6 citations
[Effect of combination immunochemotherapy with an organogermanium compound, Ge-132, and antitumor agents on C57BL/6 mice bearing Lewis lung carcinoma (3LL)].
1986 • 5 citations
Continuous-infusion spirogermanium for the treatment of refractory carcinoma of the ovary: a phase II trial.
1985 • 5 citations
Central action of sanumgerman in mice.
1986 • 2 citations
Phase II Eastern Cooperative Oncology Group Study of spirogermanium in previously treated lymphoma.
1986 • 2 citations
[Synthesis of anomeric 5-trimethylgermyl-2'-deoxyuridines and study of their antiviral and cytotoxic properties].
1985 • 2 citations
[Ability of sera from mice treated with Ge-132, an organo-germanium compound, to inhibit experimental murine ascites tumors].
1985 • 1 citations